Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Janssen reports farnesyl protein transferase inhibitors

Aug. 4, 1997

Nutraceutix in-licenses breast cancer preventive agent

Aug. 4, 1997

Lexicon Genetics granted NIH grant for DNA repair research

Aug. 4, 1997

AEterna reports promising safety profile for Neovastat

July 31, 1997

Potential antitumor agents evaluated by Taiwan researchers

July 31, 1997

Daiichi's new anticancer agent enters overseas clinical trials

July 30, 1997

Inhibitors of cyclin-dependent protein kinases disclosed by CNRS researchers

July 30, 1997

Repligen identifies angiogenic growth factor inhibitors

July 29, 1997

Targeted Genetics cancer gene therapy product approved for European clinical trials

July 28, 1997

Allos Therapeutics reports clinical results of RSR13

July 28, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...